Santa Cruz Biotechnology delivers a wide array of SCAND2 monoclonal antibodies for research applications. SCAND2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SCAND2, or S-phase cyclin A-associated protein, plays a critical role in cell cycle regulation and DNA repair processes. SCAND2 function is essential for maintaining genomic stability, and SCAND2 dysregulation has been implicated in various diseases, including cancer. Understanding SCAND2 in cellular mechanisms can provide insights into therapeutic targets and disease progression. SCAND2 monoclonal antibodies enable precise detection and quantification of SCAND2 expression levels across different experimental conditions. SCAND2 monoclonal antibodies support detailed analysis of protein localization and interactions within cellular compartments. Santa Cruz Biotechnology monoclonal antibodies for SCAND2 contribute to advancing scientific understanding of cell cycle regulation and disease mechanisms.